Vertex Pharmaceuticals
Search results
Moderna, Inc. Moderna, Inc. ( / məˈdɜːrnə / mə-DUR-nə) [4] is a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response.
Moderna’s vaccine requires two injections, given 28 days apart, to prime the immune system well enough to fight off the coronavirus. But because the vaccine is so new, researchers don’t know ...
A COVID‑19 vaccine is a vaccine intended to provide acquired immunity against severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ), the virus that causes coronavirus disease 2019 ( COVID‑19 ). Prior to the COVID‑19 pandemic, an established body of knowledge existed about the structure and function of coronaviruses causing ...
- none
- Intramuscular
- mRNA, viral, inactivated, protein
- SARS-CoV-2
Dec 22, 2020 · After releasing positive interim results from its phase 3 trial on Nov. 16, 2020, Moderna announced on Nov. 30 that its vaccine had an efficacy of 94.1% in preventing disease in adults. The ...
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim recommendations for the use of the Moderna COVID-19 (mRNA-1273) vaccine against COVID-19. This article provides a summary of those interim recommendations; you may access the full guidance document here. Here is what you need to know.
May 13, 2021 · Moderna’s vaccine against the original strain is given as two doses. Both this vaccine, and the updated booster, are mRNA vaccines (like the Pfizer vaccine). The vaccine contains genetic ...
